SS Innovations' SSi Mantra Robotic System Gains Approval for Telesurgeries in Indonesia and the Philippines, Surpasses 150 Telesurgeries Milestone

SS Innovations announces regulatory approval for telesurgeries using its SSi Mantra surgical robotic system in Indonesia and the Philippines, and reports over 150 successful telesurgeries performed, highlighting a major advancement in remote surgical care.

LA Metrowire Staff
Technology
SS Innovations' SSi Mantra Robotic System Gains Approval for Telesurgeries in Indonesia and the Philippines, Surpasses 150 Telesurgeries Milestone

SS Innovations International, Inc. (Nasdaq: SSII) announced today that its SSi Mantra surgical robotic system has received approval for telesurgeries in Indonesia and the Philippines, expanding the reach of its remote surgery capabilities. The company also reported that more than 150 cumulative telesurgeries have been successfully performed utilizing the SSi Mantra, primarily in India.

Among recent highlights, a total of 18 inter-hospital telesurgeries were performed between two Indian cities during an eight-hour period on February 14, 2026. These included 13 gastric bypass procedures performed by Dr. Mohit Bhandari from Mohak Bariatrics and Robotics in Indore, India, and 5 complex gynecological surgeries performed by Dr. Priya Bhave Chittawar from HER Health Hospital in Bhopal, India. All procedures were conducted using the SSi MantrAsana Tele Surgeon Console, a compact self-contained chair-based version of the larger SSi Mantra surgeon command center that enables portability and facilitates telesurgeries from various settings, including physician offices.

This achievement follows a robotic telesurgery marathon on December 23, 2025, from SS Innovations’ headquarters, where nine surgeons performed 24 telesurgeries within 12 hours on patients across multiple locations in India. The procedures included ten different types of surgeries, such as intricate cardiac surgeries.

“The SSi Mantra surgical robotic system continues to pioneer telesurgery, not merely in concept but in real-world practice and rapidly growing adoption by leading physicians,” said Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations. “We are thrilled to receive approval for telesurgeries utilizing the SSi Mantra in two new markets: Indonesia and the Philippines. We also are pleased to surpass the milestone of more than 150 telesurgeries successfully performed with the SSi Mantra, indicating that we are gaining significant traction in enabling state-of-the-art remote surgical care. The SSi Mantra’s advanced telesurgery capabilities empower the cross-sharing of physicians’ expertise and dismantle traditional geographical barriers to care, furthering our mission of driving equitable access to quality healthcare.”

SS Innovations is hosting the Global Multi-Specialty Robotic Surgery Conference 2026 (“SMRSC 2026”) on April 9-11, 2026, in New Delhi, India. The conference will bring together distinguished surgeons, global thought leaders, and prominent innovators in robotic and minimally invasive surgery. More than 20 live telesurgeries using the SSi Mantra are planned, spanning multiple specialties and led by top experts. Registration is available at https://ssinnovations.com/SMRSC_2026/register/.

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, supporting various procedures including cardiac surgery. For more information, visit the company’s website at ssinnovations.com.

Blockchain Registration

QR Code for Blockchain Registration